Does testosterone replacement therapy increase penis size in adult men?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Testosterone replacement therapy (TRT) does not increase the structural size (length or girth) of the penis in adult men whose pubertal development is complete; multiple clinical reviews and population studies report no association between adult testosterone levels and penile length, while TRT can improve erectile quality and sexual function [1] [2] [3]. The clear exception—supported by long-term pediatric endocrinology research—is that testosterone given before or during puberty (or short courses in infancy) can stimulate growth in boys with congenital hypogonadism or micropenis; treating those developmental deficits can move size into the normal range, but that mechanism does not apply to mature adults [4] [5] [6].
1. Adult evidence: no reliable increase in penile dimensions
The best available adult-focused reporting and clinical summaries conclude that once penile growth from puberty has finished, raising testosterone via TRT does not produce further meaningful increases in stretched penile length or girth; a University of Utah study and subsequent clinician summaries found no association between adult testosterone levels and penile length, and several patient-oriented medical sites reiterate that TRT restores function not size [1] [3] [7].
2. Developmental biology and the micropenis exception
Testosterone is essential for penile development in utero and for the rapid growth during puberty, which explains why supplemental androgen can enlarge a penis when given prepubertally or in infancy for conditions like congenital hypogonadotropic hypogonadism; clinical series show that short courses of testosterone in childhood or replacement at puberty can yield adult sizes within the population mean for affected boys [4] [5] [6].
3. Functional improvements can create the impression of change
TRT commonly improves libido, energy, and erectile firmness in men with clinically low testosterone, and stronger erections or less fat in the pubic area can make the penis appear larger even though measured structural dimensions remain unchanged; patient-facing sources emphasize improved sexual function rather than anatomical growth as the primary and expected benefit of TRT [2] [8] [7] [9].
4. Opposite problem: androgen suppression can shrink the penis
The flip side is also documented: profound androgen deprivation — for example in prostate cancer therapy — can reduce penile length over many months, indicating that very low androgen states can cause tissue regression; one trial reported reduced stretched penile length after 15 months of androgen deprivation, underscoring that normal androgen levels help maintain tissue but that restoration to normal in adults does not reverse mature size limits [10].
5. Edge cases, contested claims, and research gaps
A few niche reports and clinical notes mention limited penile response to hormonal regimens like topical testosterone or gonadotropin in specific hypogonadal pediatric cases and rare trials showing modest percent gains in micropenis patients, but these are not generalizable to typical adult TRT users [6] [11]. Some commercial or clinic blogs may overstate benefits; public-facing clinics and review sites consistently caution that TRT is not an adult penis‑enlargement therapy and warn about TRT risks [8] [12] [13]. Reporting limitations include a paucity of randomized trials specifically measuring penile structural change in otherwise healthy adult men starting TRT, so the strongest available conclusion rests on consistent biological reasoning (post‑pubertal growth arrest) and converging observational and clinical-source statements rather than a large randomized adult trial demonstrating negative results [1] [7].
6. Practical takeaway for clinicians and patients
For adult men, TRT should be considered when clinically indicated to treat symptomatic hypogonadism because it can restore sexual function, mood, and muscle mass, but it should not be pursued with the expectation of permanent increases in penile length or girth; clinicians addressing concerns about size should discuss causes (genetics, developmental history, excess suprapubic fat) and evidence-based alternatives while warning about TRT side effects and the lack of anatomical enlargement in adults [2] [11] [9].